Myfortic (180mg) 120 Tablets
Mycophenolate sodium 180mg for transplant rejection prevention.
Myfortic 180mg contains mycophenolate sodium, an immunosuppressant used after kidney, heart, or liver transplant to prevent rejection. Take twice daily on an empty stomach. Do not crush or chew. Pack of 120 tablets.
Purpose
Prophylaxis of organ rejection in patients receiving kidney, heart, or liver transplant.
Ingredients
Mycophenolate sodium 180mg per delayed-release tablet.
Warnings
Increased infection and malignancy risk. Do not use in pregnancy; use effective contraception. Avoid live vaccines. Do not stop without doctor advice.
Side Effects
Diarrhea, nausea, vomiting, infection risk, leukopenia. Increased risk of lymphoma and skin cancer. Report fever or infection.
Storage Instructions
Store below 25C in a dry place. Protect from moisture. Keep in original pack. Keep out of reach of children.
| Brand | Novartis |
| Status | Active |
Related Products
